ADRO - Aduro Biotech, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - ADRO (1435049)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
83 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
S16-1-2-10+0

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2018-09-24
ADROVan Elsas AndreaChief Scientific OfficerS - Sale$5.83-7,726256,560-3%-$45,022
2018-09-24
ADROTempleman BlaineGCS - Sale$5.81-10,262131,119-7%-$59,613
2018-09-13
ADROTempleman BlaineEVP, GCS - Sale$6.50-6,056141,381-4%-$39,360
2018-09-13
ADROVan Elsas AndreaChief Scientific OfficerS - Sale$6.50-9,754264,286-4%-$63,394
2018-09-13
ADROLew JenniferCFOS - Sale$6.50-5,623136,190-4%-$36,546
2018-09-13
ADROSacks NatalieChief Medical OfficerS - Sale$6.50-3,028173,720-2%-$19,680
2018-09-13
ADROIsaacs Stephen TPres, CEOS - Sale$6.50-24,143341,785-7%-$156,913
DM
2018-09-05
ADROIsaacs Stephen TPres, CEOS - Sale+OE$7.91-62,572214,678-23%-$495,158
2018-09-04
ADROSacks NatalieChief Medical OfficerS - Sale$7.13-4,50489,548-5%-$32,099
2018-07-17
ADROVan Elsas AndreaChief Scientific OfficerS - Sale$6.96-10,454206,215-5%-$72,803
D
2018-06-01
ADROIsaacs Stephen TPres, CEOS - Sale+OE$8.68-40,000214,678-16%-$347,004
2018-05-17
ADROTempleman BlaineGCS - Sale$8.15-2,00069,937-3%-$16,300
D
2018-05-09
ADROIsaacs Stephen TPres, CEOS - Sale+OE$8.01-40,000214,678-16%-$320,348
D
2018-04-02
ADROIsaacs Stephen TPres, CEOS - Sale+OE$8.91-40,000214,678-16%-$356,400
DM
2018-03-08
ADROIsaacs Stephen TPres, CEOS - Sale+OE$8.48-72,051214,678-25%-$611,058
2018-02-26
ADROVan Elsas AndreaChief Scientific OfficerS - Sale$6.48-6,874216,669-3%-$44,522
D
2018-01-05
ADROIsaacs Stephen TPres, CEOS - Sale+OE$7.95-7,949214,678-4%-$63,195
D
2018-01-02
ADROSchafer Gregory WCOOS - Sale+OE$7.61-20,000190,745-9%-$152,142
2017-12-18
ADROTempleman BlaineEVP, GCS - Sale$8.25-2,88469,937-4%-$23,793
D
2017-12-15
ADROBrockstedt Dirk G.EVP of Research, Dev.S - Sale+OE$8.11-65,22372,603-47%-$529,187
A
2017-09-13
ADROVan Elsas AndreaChief Scientific OfficerS - Sale$10.99-4,922202,581-2%-$54,072
D
2017-12-01
ADROBrockstedt Dirk G.EVP of Research, Dev.S - Sale+OE$9.40-10,00073,718-12%-$93,998
D
2017-12-01
ADROLew JenniferSVP of FinanceS - Sale+OE$9.46-6,60062,338-10%-$62,433
D
2017-12-01
ADROSchafer Gregory WCOOS - Sale+OE$9.34-20,000148,745-12%-$186,882
D
2017-12-01
ADROIsaacs Stephen TPres, CEOS - Sale+OE$9.38-40,000244,578-14%-$375,028
2017-11-17
ADROTempleman BlaineEVP, GCS - Sale$8.85-24358,8340%-$2,151
D
2017-11-15
ADROLew JenniferSVP of FinanceS - Sale+OE$8.95-6,60062,338-10%-$59,070
DM
2017-11-10
ADROIsaacs Stephen TPres, CEOS - Sale+OE$7.97-19,800244,578-7%-$157,723
DM
2017-11-10
ADROBrockstedt Dirk G.EVP of Research, Dev.S - Sale+OE$8.00-5,87773,718-7%-$47,040
D
2017-11-06
ADROSchafer Gregory WCOOS - Sale+OE$7.97-20,000148,745-12%-$159,312
D
2017-11-06
ADROBrockstedt Dirk G.EVP of Research, Dev.S - Sale+OE$8.04-4,12373,718-5%-$33,132
DM
2017-11-06
ADROIsaacs Stephen TPres, CEOS - Sale+OE$7.98-20,200244,578-8%-$161,157
D
2017-10-02
ADROBrockstedt Dirk G.EVP of Research, Dev.S - Sale+OE$10.59-10,00073,718-12%-$105,870
D
2017-10-02
ADROSchafer Gregory WCOOS - Sale+OE$10.75-20,000148,745-12%-$215,060
D
2017-10-02
ADROIsaacs Stephen TPres, CEOS - Sale+OE$10.78-40,000244,578-14%-$431,032
D
2017-10-02
ADROLew JenniferSVP of FinanceS - Sale+OE$10.61-6,60062,338-10%-$69,995
2017-09-18
ADROTempleman BlaineEVP, GCS - Sale$11.20-2,88458,834-5%-$32,301
2017-09-13
ADROIsaacs Stephen TPres, CEOS - Sale$10.99-12,204244,578-5%-$134,071
2017-09-13
ADROSchafer Gregory WCOOS - Sale$10.99-4,859148,745-3%-$53,380
2017-09-13
ADROBrockstedt Dirk G.EVP of Research, Dev.S - Sale$10.99-3,55773,718-5%-$39,076
2017-09-13
ADROLew JenniferSVP of FinanceS - Sale$10.99-3,55762,338-5%-$39,076
2017-09-13
ADROVan Elsas AndreaChief Scientific OfficerS - Sale$10.99-4,922207,231-2%-$54,072
2017-09-13
ADROTempleman BlaineEVP, GCS - Sale$10.99-3,55761,718-5%-$39,076
2017-09-01
ADROSacks NatalieChief Medical OfficerS - Sale$11.71-4,88545,115-10%-$57,196
D
2017-09-01
ADROSchafer Gregory WCOOS - Sale+OE$11.70-20,000120,979-14%-$233,980
D
2017-09-01
ADROLew JenniferSVP of FinanceS - Sale+OE$11.70-6,60042,595-13%-$77,242
D
2017-09-01
ADROIsaacs Stephen TPres, CEOS - Sale+OE$11.71-40,000174,682-19%-$468,596
D
2017-09-01
ADROBrockstedt Dirk G.EVP of Research, Dev.S - Sale+OE$11.69-10,00049,300-17%-$116,948
DM
2017-08-10
ADRODubensky Thomas W.Chief Scientific OfficerS - Sale+OE$11.38-50,00039,900-56%-$569,203
D
2017-08-07
ADROIsaacs Stephen TPres, CEOS - Sale+OE$12.19-40,000174,682-19%-$487,564
DM
2017-08-07
ADROSchafer Gregory WCOOS - Sale+OE$12.17-40,000120,979-25%-$486,783
D
2017-08-07
ADROBrockstedt Dirk G.EVP of Research, Dev.S - Sale+OE$12.18-10,00049,300-17%-$121,795
D
2017-08-07
ADROLew JenniferSVP of FinanceS - Sale+OE$12.17-6,60042,595-13%-$80,290
D
2017-07-03
ADROLew JenniferSVP of FinanceS - Sale+OE$11.14-12,00042,595-22%-$133,632
DM
2017-07-03
ADROIsaacs Stephen TPres, CEOS - Sale+OE$11.06-40,000174,682-19%-$442,397
D
2017-07-03
ADROBrockstedt Dirk G.EVP of Research, Dev.S - Sale+OE$11.02-10,00049,300-17%-$110,167
DM
2017-07-03
ADRODubensky Thomas W.Chief Scientific OfficerS - Sale+OE$11.33-50,00039,900-56%-$566,638
D
2017-06-28
ADROLew JenniferSVP of FinanceS - Sale+OE$11.19-12,00042,595-22%-$134,236
D
2017-06-28
ADROSchafer Gregory WCOOS - Sale+OE$11.26-40,000120,979-25%-$450,568
D
2017-06-19
ADROIsaacs Stephen TPres, CEOS - Sale+OE$10.50-40,000174,682-19%-$420,164
DM
2017-06-01
ADRODubensky Thomas W.Chief Scientific OfficerS - Sale+OE$10.03-144,30139,900-78%-$1,447,777
D
2017-06-01
ADROBrockstedt Dirk G.EVP of Research, Dev.S - Sale+OE$10.00-8,00049,300-14%-$80,020
2017-05-17
ADROBrockstedt Dirk G.EVP of Research, Dev.S - Sale$9.65-1,01149,300-2%-$9,756
2017-05-17
ADROTempleman BlaineEVP, GCS - Sale$9.65-1,64837,300-4%-$15,903
DM
2017-05-15
ADROIsaacs Stephen TPres, CEOS - Sale+OE$10.01-27,273174,682-14%-$272,950
D
2017-05-11
ADROBrockstedt Dirk G.EVP of Research, Dev.S - Sale+OE$9.72-8,00049,300-14%-$77,725
DM
2017-05-11
ADRODubensky Thomas W.Chief Scientific OfficerS - Sale+OE$9.92-5,69939,900-12%-$56,528
D
2017-04-03
ADROBrockstedt Dirk G.EVP of Research, Dev.S - Sale+OE$10.71-8,00049,300-14%-$85,645-3-3+6
D
2017-04-03
ADROIsaacs Stephen TPres, CEOS - Sale+OE$10.28-27,273172,857-14%-$280,429-3-3+6
D
2017-03-13
ADROIsaacs Stephen TPres, CEOS - Sale+OE$11.35-27,273172,857-14%-$309,434+3+5-14
D
2017-03-09
ADROBrockstedt Dirk G.EVP of Research, Dev.S - Sale+OE$11.00-8,00049,300-14%-$88,00100-23
D
2017-03-09
ADRODubensky Thomas W.Chief Scientific OfficerS - Sale+OE$10.96-25,00039,900-39%-$274,07800-23
D
2017-01-17
ADROBrockstedt Dirk G.EVP of Research, Dev.S - Sale+OE$11.86-8,00049,300-14%-$94,858+1+1+4
2017-01-11
ADROTempleman BlaineEVP, GCS - Sale$11.95-3,78537,300-9%-$45,231-4-10-13
D
2017-01-03
ADRODubensky Thomas W.Chief Scientific OfficerS - Sale+OE$11.16-25,00039,900-39%-$278,990-2-10
D
2017-01-03
ADROIsaacs Stephen TPres, CEOS - Sale+OE$11.12-27,273172,857-14%-$303,289-2-10
D
2016-12-01
ADROIsaacs Stephen TPres, CEOS - Sale+OE$10.82-27,273223,857-11%-$295,169+4+2+4
D
2016-12-01
ADRODubensky Thomas W.Chief Scientific OfficerS - Sale+OE$10.94-25,00039,900-39%-$273,500+4+2+4
2016-11-14
ADROHaghighat RossDirS - Sale$15.50-7,08881,880-8%-$109,864+1+1-18
D
2016-11-14
ADROIsaacs Stephen TPres, CEOS - Sale+OE$15.26-27,273223,857-11%-$416,050+1+1-18
D
2016-11-10
ADROLew JenniferSVP of FinanceS - Sale+OE$14.95-10,91042,595-20%-$163,105-6-8-27
DM
2016-11-10
ADROSchafer Gregory WCOOS - Sale+OE$14.78-80,00085,979-48%-$1,182,731-6-8-27
D
2016-11-10
ADRODubensky Thomas W.Chief Scientific OfficerS - Sale+OE$14.78-25,00039,900-39%-$369,408-6-8-27
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top